-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense CMO Ferenc Tracik steps down, effective April 27

PUBT·04/24/2026 13:20:49
Listen to the news
NeuroSense CMO Ferenc Tracik steps down, effective April 27
  • NeuroSense Therapeutics said Chief Medical Officer Ferenc Tracik will step down effective April 27, 2026.
  • Tracik will continue to support NeuroSense as an independent adviser.
  • Advisory work will focus on clinical development and medical strategy for PrimeC, including preparation for an upcoming Pre-NDS meeting with Health Canada.
  • Departure was not tied to any disagreement over operations, policies, or practices.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-047292), on April 24, 2026, and is solely responsible for the information contained therein.